2020
DOI: 10.1042/bst20200427
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors

Abstract: The conformation with which natural agonistic peptides interact with G protein-coupled receptor(s) (GPCR(s)) partly results from intramolecular interactions such as hydrogen bridges or is induced by ligand–receptor interactions. The conformational freedom of a peptide can be constrained by intramolecular cross-links. Conformational constraints enhance the receptor specificity, may lead to biased activity and confer proteolytic resistance to peptidic GPCR agonists. Chemical synthesis allows to introduce a varie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 66 publications
0
6
0
Order By: Relevance
“…After these modifications, dedicated proteases/transporters perform leader peptide proteolysis and export the mature product. Lanthipeptide synthetases demonstrate relaxed substrate specificity as they often tolerate changes made to the core peptide sequences, a feature that has been extensively applied to bioengineer lanthipeptides. …”
Section: Introductionmentioning
confidence: 99%
“…After these modifications, dedicated proteases/transporters perform leader peptide proteolysis and export the mature product. Lanthipeptide synthetases demonstrate relaxed substrate specificity as they often tolerate changes made to the core peptide sequences, a feature that has been extensively applied to bioengineer lanthipeptides. …”
Section: Introductionmentioning
confidence: 99%
“… 10 , 18 This characteristic enhances their potential as an alternative system for lanthipeptide bioengineering and production, and therefore, for the future design and heterologous expression of new and potent natural or close-to-nature lanthipeptides with improved or new biological or technological activities. 2 , 8 , 13 , 16 , 19 , 20 The first ProcM-like enzyme described was identified in the Gram-negative marine cyanobacterium Prochlorococcus MIT9313. 18 This enzyme is able to process up to 29 different substrates, which are named prochlorosins, a group of unusually diverse lanthipeptides 21 found in marine cyanobacterial strains, and with unknown function.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, this machinery can be used for the heterologous expression of different LanA substrates, with a special focus on lantibiotics, , a class of lanthipeptides characterized by the presence of antimicrobial activity, although also lanthipeptides with antifungal, antiviral, morphogenetic, anticonceptive, or antiallodynic functions have been described . Moreover, the lanthipeptide biosynthetic machinery has been used to design new-to-nature lanthipeptides, generating peptides with enhanced activity or stability. , The heterologous expression of lanthipeptides using the nisin biosynthetic machinery has been broadly used for the heterologous expression of newly designed antimicrobials. , However, the substrate specificity of the synthetase enzymes NisB and NisC limits the production of this type of variant compounds on a large scale. Therefore, new and promiscuous lanthipeptide synthetase enzymes with enhanced properties to fully process a large number of unrelated LanA substrates or with the ability to introduce rings with different topologies could be used for the effective heterologous production of novel bioactive lanthipeptides, either engineered variants or lanthipeptides from different (exotic) origins.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[17][18][19][20] This feature has been widely utilized for bioengineering of novel lanthipeptides. [21][22][23][24][25][26][27][28] A remarkable example of substrate tolerance is the class II lanthipeptide synthetase ProcM, which was discovered in the marine picocyanobacterium Prochlorococcus MIT9313. 29 Unlike most other lanthipeptide biosynthetic pathways, the ProcM biosynthetic gene cluster does not encode just a single precursor peptide with one modifying enzyme.…”
Section: Introductionmentioning
confidence: 99%